Press Release — Prevent Blindness and Responsum Health Announce Impressive Growth in Patient-focused Resource, “The Glaucoma Community”

Prevent Blindness and Responsum Health Announce Impressive Growth in Patient-focused Resource, “The Glaucoma Community”

The Glaucoma Community by Prevent Blindness earns 2022 sponsorship from Glaukos and Santen Pharmaceutical

​[WASHINGTON, D.C., March 1, 2022]Both Glaukos and Santen Pharmaceutical Co., Ltd., have provided grants to Prevent Blindness, the nation’s oldest eye health and safety non-profit organization, in support of The Glaucoma Community by Prevent Blindness, a patient knowledge app and online community of more than 2,000 individuals, launched in partnership with Responsum Health.

Since its inception, The Glaucoma Community has been downloaded by over 2,000 individuals and its content-heavy landing page has attracted over 50,000 individual visitors.

Thoughtfully designed to best serve people with glaucoma, The Glaucoma Community provides users with a free toolkit of useful, community-oriented features. The platform offers a dedicated social engagement page; a feature to help individuals organize their health information; and a personalized newsfeed designed to meet the needs of the user, which delivers easy-to-read summaries of important glaucoma news and information from across the internet every day. All Glaucoma Community content is written by professional health writers and vetted by a team of reviewers under the expert guidance of Prevent Blindness. Materials are available in multiple languages.

Glaucoma is an eye disease that causes loss of sight by damaging a part of the eye called the optic nerve. The damage causes vision loss in patches, most frequently one’s side, or peripheral, vision. The prevalence of glaucoma increases with age. Black and Hispanic populations, as well as women in general, are also at higher risk for the disease. Glaucoma is a serious eye disease that can lead to vision loss if not diagnosed early, treated, and controlled.

“We know that there is currently no cure for glaucoma. However, the good news is that if detected and treated early, vision loss can be significantly lessened,” said Jeff Todd, president and CEO of Prevent Blindness. “Through The Glaucoma Community, we are able to provide patients and their caregivers with the information they need to help protect their vision.”

“We are excited and grateful that both Glaukos and Santen see the value that The Glaucoma Community resource is bringing for thousands of people living with glaucoma. Their support will allow us to continue to provide this tool for free to our users,” said Founder and CEO of Responsum Health Andrew Rosenberg. “We strive to make The Glaucoma Community as valuable to our commercial partners as it is to patients, and we will continue to actively seek additional sponsors for this program in 2022 and beyond.”

For more information on The Glaucoma Community, visit responsumhealth.com/glaucoma, or contact via email at press@responsumhealth.com. For more information on glaucoma or financial assistance programs, such as Medicare coverage, please visit Prevent Blindness at preventblindness.org/glaucoma.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

About Responsum Health

With a mission of building and supporting online “knowledge communities” of chronic disease patients, Responsum Health (Latin for “the answer”) is a disruptive and innovative healthcare startup company that develops and provides free, disease-specific patient engagement platforms and apps that monitor, search, and curate the Internet – and then generate a personalized newsfeed of article summaries vetted by Responsum’s patient group and subject matter expert partners. For patients with chronic illness, Responsum Health replaces the need to sort and sift through the Internet on their own with a professionalized search and summary service; indeed, no other such app or platform exists.

Responsum Health wraps a proprietary newsfeed into a highly engaging digital platform that enables patients to comment on and rate the articles and share with their professional care team and loved ones. Responsum platforms also enable patients to share experiences through a moderated social wall, organize their health information, and find local patient support groups and services near them.

With dynamic patient knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, glaucoma, and long COVID, Responsum Health’s apps drive extremely high user engagement metrics that widely exceed industry standards. Developed from years of interviews, extensive research at Carnegie Mellon University, and collaboration with hundreds of patients worldwide, Responsum Health’s disease-specific apps are designed to improve patients’ knowledge, grow their self-confidence, and provide for the organization and coordination of their healthcare information. Today, thousands of patients and their caregivers rely on Responsum Health apps and content for their daily health information.

The company is a part of the Startup Health network of recognized healthcare innovators and counts leading corporations and organizations among its clients and partners. in delivering knowledge platforms in areas as diverse as pulmonary fibrosis, chronic kidney disease, uterine fibroids, and glaucoma. Clients and partners of Responsum Health include Astellas, Otsuka, Abbvie, Galapagos, the Allergan Foundation, Prevent Blindness, the Pulmonary Fibrosis Foundation, The White Dress Project, the Black Women’s Health Imperative, and CARE About Fibroids.

Leave a Reply

Your email address will not be published. Required fields are marked *